Among government agencies, industry and interested parties, the values vary widely on an estimated dose of perfluorooctanoate (PFOA) that would protect human health. A group of twenty-four scientists, including RHP’s Dr. Frank Pagone, were divided into three technical teams where they vetted, coalesced and analyzed relevant information and data from science, medicine, and research sources to independently develop ranges for estimated PFOA safe doses.

The results of this monumental collection of perspectives, knowledge and talent has been published in Regulatory Toxicology and Pharmacology: